Ask the Doctor
Questions about kidney disease? Risk factors? Signs and symptoms? Are you concerned about yourself, a friend or family member? Ask Dr. Spry.
October 24, 1998
William F. Keane, MD, professor and chairman of the Department of Medicine at Hennepin County Medical Center, was elected by the trustees of the National Kidney Foundation (NKF) as vice president during their annual meeting held here today. He is also vice chairman of the Department of Medicine at the University of Minnesota Medical School in Minneapolis.
Active in the National Kidney Foundation's professional education and scientific divisions, Dr. Keane is currently secretary of NKF's Scientific Advisory Board and chair of the 1999 NKF Clinical Nephrology Meeting. He has also served as co-chair of the foundation's recent consensus conference on assessing kidney disease risk through testing for protein in the urine and as a member of the foundation's Education Committee on Hypertension and Kidney Disease.
As vice president, Dr. Keane plans to focus on the widespread problem of cardiovascular disease in kidney patients by working to develop better preventive and interventional approaches to managing heart disease in patients with kidney disease. In addition, increasing public awareness and research into protein in the urine and its implications for cardiac and kidney diseases are high on his agenda. He plans to establish clinical guidelines and foster research in this area to help the foundation identify people at risk for kidney and heart disease. Ultimately, these efforts may prevent the need for dialysis treatment and reduce cardiovascular disease, one of the most significant complications of kidney disease.
Throughout his career, Dr. Keane has been instrumental in defining mechanisms involved in the process of progressive kidney destruction in diseases associated with end stage kidney failure such as diabetes, hypertension and polycystic kidney disease. Additionally, he has worked to translate these experimental insights into clinical studies that may allow for the development of new treatments that could lead to regression of chronic kidney disease.
Dr. Keane is currently associate editor of the Journal of Laboratory and Clinical Medicine and on the editorial board of Kidney International. He has been involved in numerous programs and panels for the National Institutes of Health, most recently to define methodological issues in conducting clinical trials in patients with progressive kidney disease.
Dr. Keane received his medical degree from Yale University School of Medicine and his post- graduate training at Cornell-New York Hospital.
The National Kidney Foundation is dedicated to preventing and treating kidney and urinary tract diseases, improving the health and well-being of individuals and families affected by these diseases and increasing the availability of all organs for transplantation.